Login
Toggle navigation
Videos
Categories
Trending
HealthBeacon CEO James Joyce discusses the company's €25m fundraising and going public on Euronext's growth market in Dublin with Proactive.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
The chief executive of HealthBeacon, Jim Joyce
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
AusQuest Ltd. Plans Active Drilling Campaigns in Peru and Australia, Says MD Graham Drew
00:10:00
El Al Israel Airlines Ltd. CEO Interview
00:10:00
DJ Deb on Market Trends: Investment Strategies Amid Rising Valuations | Dipanjan Deb, CEO, Francisco Partners.
00:10:00
Permira's Strategic Insights and Future Directions: A Conversation with Kurt Bjorklund | Kurt Bjorklund, Co-Managing Partner, Permira.
00:10:00
Strategic Challenges and Opportunities in the Merged Asset Management Company
00:10:00
recognize and celebrate the most compelling startups|Arash Ferdowsi,Angel Investor,Arash Ferdowsi
00:10:00
Unlock Financial Freedom with the Infinite Banking Concept
00:10:00
Responsible Mining in Romania: Euro Sun Mining's Rovina Valley Project
00:10:00
Silvercorp Metals Interview with Lon Shaver on Assay TV
00:10:00
Making money while markets go nowhere: smart money coming|Mark Pearson, ACA, CFA,Co-Founder and Head of Portfolio Management,Arcus Japan Long/Short Fund
00:10:00
Flagstone FM's Investment Principles | DANIEL STOUS - SHAREHOLDER & LEAD WEALTH ADVISOR of Flagstone Financial Management
00:10:00
Insights from Rajitha Kariyawasan: Hayleys Group MD on Leadership and Six Sigma Excellence|RAJITHA KARIYAWASAN,Managing Director,Haycarb Plc